Initial Combination Therapy in a Newly Diagnosed Patient
Posted July 25, 2013 by Doron Schneider, MD, FACPDoron Schneider, MD and Jack Leahy, MD discuss the treatment option of initial combination therapy in a newly diagnosed T2DM patient.
Doron Schneider, MD and Jack Leahy, MD discuss the treatment option of initial combination therapy in a newly diagnosed T2DM patient.
Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of bariatric surgery as an initial treatment option.
Doron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatment options.
Listen to the podcast or read the transcript
Doron Schneider, MD and Jack Leahy, MD discuss the effectiveness and challenges of bariatric surgery. (7:18)
Doron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatment options. (12:08)
Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of combination therapy for as initial treatment. (17:40)
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD. (50:19)
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD
A 38-year-old Caucasian male presents to your office reporting symptoms of fatigue, thirst, and weight loss. He has not been to a physician since his late 20s. Your physical examination shows high blood pressure (150/96 mmHg) and a BMI (body-mass index) of 36 kg/m2. There is a family history of cardiovascular disease, although the patient himself reports having no personal history of cardiac symptoms or cardiovascular events.